Former FDA ODE V Director Weintraub
This article was originally published in The Tan Sheet
Executive Summary
Former FDA ODE V Director Weintraub: Michael Weintraub, MD, joins Washington, D.C.-based reimbursement consulting firm The Lash Group as senior scientist. Working part-time, he is assisting pharmaceutical companies in designing their studies and overall research programs. Weintraub left FDA's Office of Drug Evaluation V on July 3, and was named to the Tufts University Center for the Study of Drug Development advisory board at the end of July ("The Tan Sheet" July 27, In Brief). Lash Group has been acquired by the supply channel management firm Bergen Brunswig, the company announces Sept. 2. Under the merger, it will operate separately under Bergen's Integrated Commercialization Solutions division...